Data / Form D filings / NovaVive Inc.
NovaVive Inc.: Form D filings
NovaVive Inc., a biotechnology company in Napanee, Ontario, Canada, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on December 20, 2018, reports an offering of $125,000 with nothing sold yet to 1 investor.
Find out what NovaVive Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 15 Dairy Avenue, Napanee, Ontario, Canada, K7R 1
- Phone
- (613) 308-9788
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Year incorporated
- 2014
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1676765
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 20, 2018 | New notice | $125,000 | $0 | $125,000 | 1 | Dec 12, 2018 | sec.gov |
| Jun 20, 2016 | New notice | $100,000 | $0 | $100,000 | 1 | May 10, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stan Alkemade | Director | |
| Jennifer Shea | Director | |
| Graeme McRae | Executive Officer, Director |
Every Form D from the week of Dec 17, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NovaVive Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.